MIT scientists design new and versatile nanosensor; DNA-based drug-targeting system developed;

> MIT scientists have created nanosensors that can perform both MRI and fluorescent imaging in animals. More

> Scientists have created a drug-targeting system comprising ultraviolet light and Aptamers, or short single strands of DNA. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.